Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 23.13 billion as of July 15, 2025. Its market cap has decreased by -24.62% in one year.

Market Cap

23.13B

Enterprise Value

21.88B

Revenue

43.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

137.00

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 23.13B, an increase of 438.50%. That is a compound annual growth rate of 18.33%.

Market Cap History

Date	Market Cap	% Change
Jul 14, 2025	23.21B	-45.03%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	188.45B
PharmaEssentia	175.63B
Bora Pharmaceuticals Co., LTD.	84.20B
Lotus Pharmaceutical	55.88B
Oneness Biotech	29.13B
Polaris Group	29.05B
Center Laboratories	26.46B
TaiMed Biologics	23.08B

Market Cap Rankings